Proteome-wide Map of Targets of T790M-EGFR-Directed Covalent Inhibitors-Reference-Cited by-同舟云学术

Proteome-wide Map of Targets of T790M-EGFR-Directed Covalent Inhibitors

Published:2017-11 Issue:11 Volume:24 Page:1388-1400.e7
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Niessen Sherry,Dix Melissa M.,Barbas Sabrina,Potter Zachary E.,Lu Shuyan,Brodsky Oleg,Planken Simon,Behenna Douglas,Almaden Chau,Gajiwala Ketan S.,Ryan Kevin,Ferre RoseAnn,Lazear Michael R.,Hayward Matthew M.,Kath John C.,Cravatt Benjamin F.

Funder

NIH

National Cancer Institute

Pfizer

Skaggs Institute for Chemical Biology

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference61 articles.

1. Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies;Advani;J. Clin. Oncol.,2013

2. 136O: Osimertinib combined with durvalumab in EGFR-mutant non-small cell lung cancer: Results from the TATTON phase Ib trial;Ahn;J. Thorac. Oncol.,2016

3. CHK2 kinase: cancer susceptibility and cancer therapy—two sides of the same coin?;Antoni;Nat. Rev. Cancer,2007

4. Proteome-wide covalent ligand discovery in native biological systems;Backus;Nature,2016

5. Irreversible protein kinase inhibitors: balancing the benefits and risks;Barf;J. Med. Chem.,2012

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-kinase off-target inhibitory activities of clinically-relevant kinase inhibitors;European Journal of Medicinal Chemistry;2024-09

2. Design, preparation and biological evaluation of new Rociletinib-inspired analogs as irreversible EGFR inhibitors to treat non-small-cell-lung cancer;Bioorganic & Medicinal Chemistry;2024-09

3. Multi-tiered chemical proteomic maps of tryptoline acrylamide–protein interactions in cancer cells;Nature Chemistry;2024-08-13

4. Dual-Probe Activity-Based Protein Profiling Reveals Site-Specific Differences in Protein Binding of EGFR-Directed Drugs;ACS Chemical Biology;2024-07-25

5. Chemical Proteomics–Guided Discovery of Covalent Ligands for Cancer Proteins;Annual Review of Cancer Biology;2024-06-12